Safety, Pharmacokinetics, and Pharmacodynamics of CC‐90001 (BMS‐986360), a c‐Jun N‐terminal Kinase Inhibitor, in Phase 1 Studies in Healthy Participants.

Saved in:
Bibliographic Details
Title: Safety, Pharmacokinetics, and Pharmacodynamics of CC‐90001 (BMS‐986360), a c‐Jun N‐terminal Kinase Inhibitor, in Phase 1 Studies in Healthy Participants.
Authors: Ye, Ying1 (AUTHOR), Gaudy, Allison1 (AUTHOR), Thomas, Michael1 (AUTHOR), Reyes, Josephine1 (AUTHOR), Burkhardt, Barbara1 (AUTHOR), Horan, Gerald1 (AUTHOR), Liu, Liangang1 (AUTHOR), Chen, Jian1 (AUTHOR), Ghosh, Atalanta1 (AUTHOR), Carayannopoulos, Leonidas N.1 (AUTHOR), Tatosian, Daniel A.1 (AUTHOR) daniel.tatosian@bms.com, Palmisano, Maria1 (AUTHOR)
Source: Clinical Pharmacology in Drug Development. Dec2022, Vol. 11 Issue 12, p1394-1404. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:2160763X
DOI:10.1002/cpdd.1178